Background-The available amount of detailed long-term data in patients with Wolff-Parkinson-White syndrome is limited, and no prospective electrophysiological studies looking at predictors of malignant arrhythmia are available. Methods and Results-Among 8575 symptomatic Wolff-Parkinson-White patients with atrioventricular reentrant tachycardia referred for electrophysiological test, 369 (mean age, 23Ϯ12.5 years) declined catheter ablation and were followed up. The primary end point of the study was to evaluate over a 5-year follow-up the predictors and characteristics of patients who develop malignant arrhythmias. After a mean follow-up of 42.1Ϯ10 months, malignant arrhythmias developed in 29 patients (mean age, 13.9Ϯ5.6 years; 26 male), resulting in presyncope/ syncope (25 patients), hemodynamic collapse (3 patients), or cardiac arrest caused by ventricular fibrillation (1 patient). Of the remaining 340 patients, 168 (mean age, 34.2Ϯ9.0 years) remained asymptomatic up to 5 years, and 172 (mean age, 13.6Ϯ5.1 years) had benign recurrence, including sustained atrioventricular reentrant tachycardia (132 patients) or atrial fibrillation (40 patients). Compared with the group with no malignant arrhythmias, the group with malignant arrhythmias showed shorter accessory-pathway effective refractory period (PϽ0.001) and more often exhibited multiple accessory pathways (PϽ0.001), and atrioventricular reentrant tachycardia triggering sustained pre-excited atrial fibrillation was more frequently inducible (PϽ0.001). Multivariable analysis demonstrated that short accessory-pathway effective refractory period (PϽ0.001) and atrioventricular reentrant tachycardia triggering sustained pre-excited atrial fibrillation (PϽ0.001) were independent predictors of malignant arrhythmias. Conclusions-Symptomatic patients with Wolff-Parkinson-White syndrome generally have a good outcome, and predictors of malignant arrhythmias are similar to those reported for asymptomatic patients with ventricular pre-excitation. (Circulation. 2012;125:661-668.)
T he Wolff-Parkinson-White (WPW) syndrome is a disorder characterized by presence of 1 or multiple accessory pathways (APs) that predispose patients to frequent episodes of arrhythmia, usually recurrent paroxysmal supraventricular tachycardia or atrial fibrillation (AF), but catastrophic arrhythmic events and/or sudden cardiac death can also occur. The syndrome significantly decreases quality of life, particularly in adolescents and young people, mainly because of its lifetime risk of developing malignant arrhythmias (MAs) or of dying suddenly, which at present cannot be predicted. Unfortunately, specific risk factors to prevent MA, aborted sudden death, or sudden death are not well established, because no systematic long-term follow-up studies in large cohorts of symptomatic patients looking at predictors of such catastrophic and tragic events are currently available. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Catheter ablation (radiofrequency ablation) is now safe and effective, but the procedure frequently requires the application of radiofrequency energy on challenging sites such as septal regions or multiple APs, which increases the procedure-related complications. Despite a low risk of sudden death, current guidelines in patients with WPW syndrome recommend routine electrophysiological testing (EPT) with a liberal indication for catheter ablation. 1 As a result, patients with ventricular pre-excitation presenting with a first episode of supraventricular tachycardia are increasingly referred for both EPT and catheter ablation of APs, but in the absence of risk stratification, many of them, particularly children or adolescents, may decline or postpone catheter ablation as a definitive treatment. The purpose of this prospective longterm follow-up study was to define risk factors and predictors of MA among symptomatic WPW patients presenting with a first episode of atrioventricular reentrant tachycardia (AVRT).
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Methods
Study Population
We conducted an observational cohort study. The cohort consisted of consecutive patients with WPW syndrome presenting with a firstdetected and documented episode of supraventricular tachycardia who after EPT declined catheter ablation and were followed up. Patients were excluded if they had experienced syncope or MA, had been referred for reasons other than arrhythmia evaluation or underwent catheter ablation, or had a history of recent (Ͻ12 months) myocardial infarction or heart surgery. Their assessment included prior clinical history, physical examination, 12-lead ECG, chest x-ray, echocardiography, and invasive EPT. Participants or their family members gave written informed consent at the time of follow-up ascertainment. The study was approved by the Hospital Ethics Committee.
Baseline EPT
Patients underwent a baseline invasive EPT as previously described. 13 Children underwent EPT under general anesthesia if necessary, whereas local anesthesia and sedation were used in adolescents and the adult population. Briefly, quadripolar catheters were typically placed in the right atrial atrium, His bundle position, right ventricular apex, and coronary sinus for pacing and recording. After baseline intervals were obtained, the AP antegrade effective refractory period (AP-AERP) was determined at the same cycle length with progressively premature extrastimuli until loss of pathway conduction was noted. The minimum atrial cycle length to which AP conduction could be maintained (1:1 conduction) was also determined with right atrial pacing. Atrial and ventricular extrastimulation with progressively shorter coupling intervals was performed to induce AVRT until the ERPs of the atrium and ventricle were achieved. Inducibility of AF was attempted with a conservative protocol by ramp pacing starting at a cycle length of 300 milliseconds up to a maximum of 150 milliseconds over 10 seconds, but a shorter cycle length or a longer period of stimulation was not used. Inducible arrhythmias were defined as sustained if they lasted Ͼ1 minute. Tachyarrhythmia inducibility was defined as reproducible induction of sustained AVRT and/or AF. There was a waiting period of 3 minutes for AVRT to degenerate into AF. The identification of multiple APs was based on the following criteria: (1) atypical patterns of pre-excitation on the ECG, (2) change in pre-excited QRS morphology during AF, (3) differing patterns of antegrade and retrograde conduction at different pacing cycle lengths and sites, and (4) varying patterns of retrograde atrial activation sequence during AVRT or ventricular pacing or from orthodromic AVRT to antidromic AVRT. A repeat EPT was performed in all patients who had arrhythmia recurrence with the same protocol and catheters as used in the first EPT.
Definitions
An MA was considered as an episode of a potentially life-threatening arrhythmia, which was defined as an episode of documented sustained (Ͼ1 minute) AF with a shortest pre-excited RR interval of Յ250 milliseconds. Hemodynamic collapse and cardiac arrest were defined as a sudden loss of effective blood flow owing to very rapid AF (hemodynamic collapse) or ventricular fibrillation (cardiac arrest) requiring cardiopulmonary resuscitation and/or electric defibril-lation not associated with an acute myocardial infarction or other transient factors.
End Point
The primary end point of the study was to evaluate over a 5-year follow-up period the predictors and characteristics of patients developing a malignant recurrence after baseline EPT.
Follow-Up
Follow-up began when patients were discharged. At referral, patient data were prospectively recorded in a computerized database. Follow-up consisted of outpatient visits at 1, 3, 6, 9, and 12 months in the first year and every 6 months thereafter. Each visit included symptom assessment, physical examination, 12lead ECG, and 48-hour Holter monitoring; unscheduled visits occurred when clinical circumstances required or when patients experienced symptoms suggestive of arrhythmias. Patients were discharged without antiarrhythmic drugs, and the decision to undergo long-term antiarrhythmic drug therapy was left to the referring physician and could be stopped at the physician's discretion. Patients, relatives, and primary physicians were also advised to report by phone or e-mail any adverse events and hospitalizations occurring between visits.
Statistical Analysis
Continuous data are expressed as meanϮSD and compared by use of the unpaired t test. For categorical variables, the 2 test and the Fisher exact test were applied. Factors that were associated with MA after baseline EPT were identified by univariable and multivariable analyses through the use of the Cox proportional hazards model. In the Cox multivariate regression model, we used backward-stepwise model selection with the removal testing based on the Wald statistic.
Covariates included in the model were age at enrollment, baseline AP-AERP, multiple pathways, and baseline inducibility of AVRT triggering AF. All tests of significance were 2 sided. A value of PϽ0.05 was considered significant.
Results
Between January 1997 and January 2007, of 8575 consecutive screened patients with WPW syndrome and palpitations resulting from a first documented episode of AVRT (mean cycle length, 265.5Ϯ13.8 milliseconds) referred to our Arrhythmology Department for EPT and catheter ablation, a total of 379 patients (4.4%) after EPT refused or did not perform the ablative procedure because written informed consent was given only for EPT and not for catheter ablation (142 patients) or because of patient discomfort and anesthesiological or vascular complications of EPT. Ten patients were lost to follow-up without any further information on their vital status and were excluded from analysis. A total of 369 patients (mean age, 23Ϯ12.5 years; 230 male) constitute the study population.
Baseline EPT and Arrhythmia Recurrence at Follow-Up
The baseline characteristics of patients who did and did not undergo catheter ablation were similar (Table 1) . Before EPT, a 24-hour Holter monitoring was occasionally performed in 15 patients, but no sustained arrhythmia was documented. All patients were inducible for sustained AVRT; nonsustained self-terminating AF (shortest pre-excited RR interval, 280Ϯ25 milliseconds) was induced in 65 patients by burst pacing at 200 to 150 milliseconds. Orthodromic AVRT was induced in 301 of the 369 patients; antidromic AVRT was induced in 58 patients; and both tachycardias were inducible in 10 patients. AVRT degenerated into sustained pre-excited AF in 11 patients, spontaneously reverting to sinus rhythm after 1.6Ϯ0.5 minutes (Figures 1 and 2) , and in 3 of them, AVRT was antidromic. The length of the AVRT cycle was 251.4Ϯ10 milliseconds, and the shortest RR interval during AF was 220Ϯ15 milliseconds. The mean AP-AERP was 278.4Ϯ32.2 ms; overall, multiple APs were found in 14 patients (3.8%).
After a mean follow-up of 42.7Ϯ9.6 months, 201 patients (54.5%) had a recurrent arrhythmia, but only 29 had a malignant presentation and 168 patients (45.5%) remained asymptomatic at 5 years after EPT despite the fact that almost all of them (165 of 168, 98%) did not receive any antiarrhythmic drug therapy. A comparison of the clinical and electrophysiological characteristics of patients with and without arrhythmia recurrence is shown in recurrent arrhythmia were younger with faster conducting APs or multiple APs and more likely experienced spontaneous degradation to AF from AVRT ( Table 2 ). MAs resulted in syncope/presyncope in 25 patients (Figure 3) ; rapid pre-excited AF caused hemodynamic collapse in 3 patients; and VF caused cardiac arrest in 1 patient, requiring defibrillation without neurological sequelae. When MA developed, 20 patients were at rest, 2 were sleeping, and 7 were exercising. At the time of MA occurrence, all but 2 patients had stopped antiarrhythmic drug therapy for at least 12 months. A comparison of the clinical and electrophysiological characteristics of patients with arrhythmia recurrence is shown in Table 3 . Patients with a recurrent MA were more often male but were not younger than the cohort with recurrent MAs. AP characteristics were more severe in patients with recurrent MAs (Table 3 ). Patients with recurrences had a second EPT and successful radiofrequency catheter ablation. Repeat EPT confirmed the baseline electrophysiological differences Figure 1 . The sustained pre-excited atrial fibrillation (AF; A), as induced by atrioventricular reentrant tachycardia, after 1.5 minutes spontaneously reverted to sinus rhythm (B). The paper speed is 25 mm/s. between these 2 groups of patients, although there were different follow-up periods between the 2 groups and catheter ablation revealed a higher number of multiple APs in both groups ( Table 4 ).
Identification of Predictors of MAs
We performed univariable and multivariable analyses to investigate whether clinical and electrophysiological vari-ables are associated with the occurrence of MA events at follow-up (Tables 5 and 6 ). Univariable correlates were age (PϽ0.001), multiple APs (PϽ0.001), AP-AERP at first EPT (PϽ0.001), and spontaneous occurrence of AF after initiated AVRT (PϽ0.001). Multivariable correlates were only AP-AERP (PϽ0.001) and AF after AVRT (PϽ0.001).
Discussion
Main Findings
This is a long-term study on a unique patient cohort-369 symptomatic WPW patients with a first documented episode of sustained AVRT-that was studied prospectively over a long time without ablative strategy. The results demonstrated that, over a 5-year follow-up period, almost all initially symptomatic WPW patients (Ͼ90%) did not experience recurrent arrhythmia or had benign recurrences, although most of them were not on antiarrhythmic drugs, which suggests that antiarrhythmic therapy should not be recommended routinely when patients do not want ablation. In contrast, a malignant presentation, including rapid preexcited AF, developed in 7% of cases, whereas cardiac arrest occurred just in 4 patients (1.4%), which confirms that symptomatic patients with WPW generally have a good outcome and that the risk of sudden death is low. Multivariable predictors were only AP-AERP and AF after AVRT. These findings provide strong evidence that EPT is useful for identifying patients at higher risk in whom catheter ablation should be performed contextually with EPT to eliminate the lifetime risk of sudden death. Catheter ablation may be indicated liberally for patients at lower risk, who represent the vast majority of initially symptomatic patients.
Risk of Sudden Death in WPW Syndrome
WPW syndrome is associated with a small but lifetime risk of catastrophic events and/or sudden cardiac death that is attributed to the occurrence of MAs resulting from rapid anterograde AP conduction in the setting of AF. Although the risk of sudden cardiac death in WPW syndrome is currently estimated to be Ϸ25%/y or 3% to 4% per lifetime, 1 the true incidence and risk of developing MAs, cardiac arrest, and/or sudden cardiac death in such a population are unclear and cannot be predicted. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Whether symptomatic patients with WPW syndrome are at higher risk of MA and/or sudden death than asymptomatic patients is also unknown. In the present study, over a 5-year follow-up period, MAs occurred in Ϸ7% SHD indicates structural heart disease; AP, accessory pathway; AP-AERP1, accessory-pathway antegrade effective refractory period at first electrophysiological test; AP-AERP2, accessory-pathway antegrade effective refractory period at repeat electrophysiological test; AVRT-AF1, atrioventricular reentrant tachycardia triggering atrial fibrillation at first electrophysiological test; AVRT-AF2, atrioventricular reentrant tachycardia triggering atrial fibrillation at repeat electrophysiological test; PS, posteroseptal; RFW, right free wall; LFW, left free wall; and AS, anteroseptal. of subjects, but hemodynamic collapse and cardiac arrest developed in Ϸ1.4% (0.8%/y), which suggests that sudden death is indeed a rare event. 1
Electrophysiological Profile of the Symptomatic WPW Patient at Risk
In the present study, many patients presenting malignant recurrences were young (mean age, 13 years), and most of them were male. Compared with patients experiencing no malignant recurrences, they have shorter baseline AP-AERP and a higher number of APs and more frequently have inducible sustained AVRT that rapidly degenerates into sustained AF, but age was not different between the 2 groups. Inducible AVRT alone was common in both groups and therefore was not a predictor. The baseline electrophysiological profile of patients who had MAs did not differ over time and was characterized by AVRT triggering AF in a substantial number of patients, remaining significantly different from the electrophysiological profile of patients who had benign recurrences. Recently, we have reported in a large number of patients with asymptomatic ventricular pre-excitation that the risk of MA and/or sudden death is low and that it can be predicted by short AP-AERP, inducibility of AVRT triggering AF, and multiple APs. [13] [14] [15] [16] [17] These findings suggest that predictors of a bad outcome in symptomatic WPW syndrome are the same as for asymptomatic patients, depending mostly on intrinsic electrophysiological characteristics of AP rather than on the presence or absence of symptoms. Our experience also suggests that the concomitant presence of short AP-AERP and multiple APs facilitates degeneration of AVRT into rapid pre-excited AF, leading to MAs and sudden death.
In the present study, baseline EPT showed this electrophysiological marker in 3% of the study population as a whole and 30% of those with MA, but it characterized almost all patients (80%) after MA occurrence.
Clinical Implications
The results of the present study suggest that patients with WPW syndrome should undergo an EPT and ablation as indicated. Catheter ablation may be recommended liberally in almost all initially symptomatic patients presenting with AVRT. However, in a minority of patients at risk, the ablative procedure should be done contextually to EPT to prevent MA and/or sudden death.
Conclusions
Although the majority of initially symptomatic WPW patients remain asymptomatic after the first episode of AVRT or may experience a benign recurrence over a 5-year follow-up period, a minority of them may experience catastrophic arrhythmic events, including syncope, hemodynamic collapse, and/or cardiac arrest. Short AP-AERP and AVRT triggering AF are independent predictors of the risk, which emphasizes the need of catheter ablation at the time of EPT in a selected group of patients to definitively eliminate their lifetime risk.
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